Jaqueline França-Costa

Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis

C. Sorgi, L. Faccioli, P. Bozza, 2020, iScience.

Resolvin D1 drives establishment of Leishmania amazonensis infection

P. Bozza, Hayna Malta-Santos, Jaqueline França-Costa, 2017, Scientific Reports.

Arginase 1 is a marker of protection against illness in contacts of leprosy patients

G. M. Sperandio da Silva, P. Bozza, M. Bozza, 2022, Scientific Reports.

Exposure of Phosphatidylserine on Leishmania amazonensis Isolates Is Associated with Diffuse Cutaneous Leishmaniasis and Parasite Infectivity

M. Barcinski, Jaqueline França-Costa, L. Soong, 2012, PloS one.

Systems Approach Reveals Nuclear Factor Erythroid 2-Related Factor 2/Protein Kinase R Crosstalk in Human Cutaneous Leishmaniasis

A. M. Saliba, U. Lopes, R. Khouri, 2017, Front. Immunol..

Prostaglandin E2/Leukotriene B4 balance induced by Lutzomyia longipalpis saliva favors Leishmania infantum infection

J. C. Miranda, P. Bozza, C. Brodskyn, 2014, Parasites & Vectors.

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis

S. Reed, Jaqueline França-Costa, Nívea F Luz, 2017, PLoS neglected tropical diseases.

Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis.

R. Khouri, P. Bozza, Hayna Malta-Santos, 2016, The Journal of infectious diseases.

Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils

J. C. Miranda, P. Bozza, C. Brodskyn, 2011, Journal of leukocyte biology.

Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial

Cristiana T. Trinconi, Silvia R B Uliana, J. K. Yokoyama-Yasunaka, 2018, Tropical medicine & international health : TM & IH.